Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pasqualino Malandrino is active.

Publication


Featured researches published by Pasqualino Malandrino.


The Journal of Clinical Endocrinology and Metabolism | 2013

Papillary Thyroid Microcarcinomas: A Comparative Study of the Characteristics and Risk Factors at Presentation in Two Cancer Registries

Pasqualino Malandrino; Gabriella Pellegriti; Marco Attard; Maria Antonia Violi; Carla Giordano; Laura Sciacca; Concetto Regalbuto; Sebastiano Squatrito; Riccardo Vigneri

CONTEXT Papillary thyroid microcarcinoma (PTMC) is an indolent neoplasia, often asymptomatic and discovered incidentally. Some PTMCs, however, exhibit a more aggressive behavior, frequently recur, and can even cause cancer-related death. OBJECTIVE The aim of this study was to evaluate the prevalence of PTMCs and the associated risk factors at presentation in 2 thyroid cancer registries from areas with different genetic and environmental characteristics. DESIGN AND PATIENTS We conducted a retrospective, observational study of all incident cases of PTMCs recorded over a 5-year period in the Sicilian Regional Registry for Thyroid Cancer (SRRTC) and in the Surveillance Epidemiology and End Results (SEER) US registry. SETTING The study took place at an academic hospital. RESULTS The incidence of PTMCs was much higher in Sicily (1777 PTMC diagnosed in 2002-2006; age-standardized incidence rate for the world population [ASRw] = 5.8 per 100 000) than in the United States (14 423 PTMC in the period 2004-2008; ASRw = 2.9 per 100 000). Within the SRRTC, a significantly higher incidence was observed in the volcanic area (ASRw = 10.4 vs 4.6 in the rest of Sicily). In Sicily, the female to male ratio was higher, and PTMC patients were younger. In both registries, a significant inverse correlation was observed between age and tumor size. Young patients (≤45 y) exhibited a higher frequency of nodal metastases. CONCLUSIONS PTMC incidence is twice as high in Sicily compared with the United States, and within Sicily, the incidence is twice as high in the volcanic area. In young patients, PTMCs are larger at presentation and exhibit more risk factors. In both registries, more than 35% of PTMCs exhibited 2 or more risk factors, suggesting that they may require surgery and follow-up similar to that of larger carcinomas.


The Journal of Clinical Endocrinology and Metabolism | 2013

Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension.

Gabriella Pellegriti; Gabriella Lumera; Pasqualino Malandrino; Adele Latina; Romilda Masucci; Claudia Scollo; Angela Spadaro; Giulia Sapuppo; Concetto Regalbuto; V. Pezzino; Riccardo Vigneri

CONTEXT Differentiated thyroid cancer (DTC) in thyroglossal duct cysts is uncommon. The requirement of total thyroidectomy and lymph node dissection is still controversial. SETTING The study was performed in a referral thyroid cancer center at an academic hospital. PATIENTS We conducted a single center retrospective study of a consecutive series of 26 patients with DTC in thyroglossal duct cyst, all having undergone cyst resection and total thyroidectomy. MAIN OUTCOME MEASURES Diagnostic modalities, surgical treatment, histopathological features, and clinical outcome were included in the study. RESULTS Thyroglossal duct cyst cancer histotype was papillary in 23 of 26 patients (88.5%) and follicular-Hurthle in 3 of 26 cases (11.5%). A concomitant papillary DTC in the thyroid gland was found in 16 of 26 cases (61.5%), and it was multifocal in 8 of 16 cases (50%). At presentation, the patients with cancer in both the thyroglossal duct cyst and the thyroid were older than the patients who only had cancer in the thyroglossal duct cyst (44.9 ± 7.6 vs 32.0 ± 12.7; P = .006). Lymph node dissection, performed in 17 of 26 patients (65.4%), indicated that the central compartment was involved in 6 patients (35.3%, all having cancer also in the thyroid), the laterocervical compartments in 10 patients (58.8%), and the submental in 4 (23.5%). Six patients (23.1%) had persistent disease at 6-year median follow-up. CONCLUSIONS DTC in thyroglossal duct cysts occurs at a younger age and with more aggressive features at presentation. Concomitant cancer in the thyroid and lymph node metastases is present in most cases. Lymph node compartment involvement is different from that of cancers in the thyroid gland. Therefore, surgical treatment should include both thyroglossal duct cyst resection and total thyroidectomy, with individualized surgical nodal dissection. Subsequent management should follow current DTC guidelines.


Journal of Endocrinological Investigation | 2012

The tall cell variant of papillary thyroid carcinoma: Clinical and pathological features and outcomes

Concetto Regalbuto; Pasqualino Malandrino; Francesco Frasca; Gabriella Pellegriti; R. Le Moli; Riccardo Vigneri; V. Pezzino

Background: The tall cell variant (TCV) is a relatively rare variant of papillary thyroid cancer. Since a controversy exists whether or not the TCV has a worse outcome, the aim of our study was to retrospectively compare the clinicopathological features and outcomes in a group of TCV patients and a larger group of patients with classical papillary thyroid carcinoma (cPTC). Subjects and methods: Data from 30 TCV and 293 cPTC patients were analyzed. Among the 293 cPTC, we also selected a “high-risk” cPTC group (no.=103) that was treated with the same protocol used for the TCV patients. All data were managed by Cox analysis. Results: Compared to all cPTC patients, TCV subjects displayed only a significantly higher rate of extrathyroid extension. At multivariate analysis, TCV was not an independent variable for the prediction of a high risk of persistent/recurrent disease. At the last follow-up observation, there was no difference in the disease status between the TCV and all cPTC patients. Moreover, “high-risk” cPTC patients had a significant increase in persistent/recurrent disease. Conclusions: In our study, although the TCV histotype is associated with a higher prevalence of extrathyroid extension, it is characterized by an outcome that is not significantly different from that of all cPTC patients and is more favorable than that of “high-risk” cPTC patients. Only those TCV patients classified as “high risk” based on specific pathological and clinical features, according to current guidelines, should be treated aggressively, such as with a total thyroidectomy, neck lymph node dissection or ablative radioiodine treatment.


Journal of Cellular Physiology | 2014

Biological Effects of Insulin and Its Analogs on Cancer Cells With Different Insulin Family Receptor Expression

Laura Sciacca; Maria Francesca Cassarino; Marco Genua; Paolo Vigneri; Maria Giovanna Pennisi; Pasqualino Malandrino; Sebastiano Squatrito; V. Pezzino; Riccardo Vigneri

Hyperinsulinemia is a likely cause of the increased cancer incidence and mortality in diabetic patients, but its role is difficult to define in vivo. Previous in vitro studies testing the mitogenic potential of insulin and its analogs provided incomplete and sometimes contradictory results. To better evaluate cancer cell responsiveness to insulin, to its analogs and to IGF‐I, we measured under identical experimental conditions cell proliferation, invasiveness, and foci formation in six cancer cell lines with different insulin receptor family expression levels. The cancer cells studied have a different expression of insulin receptor (IR), its isoforms (IR‐A and IR‐B), and of the IGF‐I receptor. The data indicate that insulin stimulates proliferation in all cancer cell lines, invasiveness in some, and foci formation in none. Cancer cell responses to insulin (and IGF‐I) are not related to receptor expression levels; moreover, hormone‐stimulated proliferation and invasiveness are not correlated. IGF‐I is a more potent stimulator than insulin in most but not all cancer cell lines. Insulin analogs including M1 and M2 Glargine metabolites stimulate cancer cells similar to insulin. However, exceptions occur for specific analogs in particular cancer cells. In conclusion, in vitro insulin is an effective growth factor for all cancer cells but the biological response to insulin cannot be predicted on the basis of receptor expression levels. In the clinical setting, these observations should be taken in account when deciding treatment for diabetic patients who are at risk of undiscovered cancer or survivors of oncological diseases. J. Cell. Physiol. 229: 1817–1821, 2014.


Endocrine | 2016

Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Pasqualino Malandrino; Marco Russo; Anna Ronchi; Claudio Minoia; Daniela Cataldo; Concetto Regalbuto; Carla Giordano; Marco Attard; Sebastiano Squatrito; Francesco Trimarchi; R. Vigneri

The increased thyroid cancer incidence in volcanic areas suggests an environmental effect of volcanic-originated carcinogens. To address this problem, we evaluated environmental pollution and biocontamination in a volcanic area of Sicily with increased thyroid cancer incidence. Thyroid cancer epidemiology was obtained from the Sicilian Regional Registry for Thyroid Cancer. Twenty-seven trace elements were measured by quadrupole mass spectrometry in the drinking water and lichens (to characterize environmental pollution) and in the urine of residents (to identify biocontamination) in the Mt. Etna volcanic area and in adjacent control areas. Thyroid cancer incidence was 18.5 and 9.6/105 inhabitants in the volcanic and the control areas, respectively. The increase was exclusively due to the papillary histotype. Compared with control areas, in the volcanic area many trace elements were increased in both drinking water and lichens, indicating both water and atmospheric pollution. Differences were greater for water. Additionally, in the urine of the residents of the volcanic area, the average levels of many trace elements were significantly increased, with values higher two-fold or more than in residents of the control area: cadmium (×2.1), mercury (×2.6), manganese (×3.0), palladium (×9.0), thallium (×2.0), uranium (×2.0), vanadium (×8.0), and tungsten (×2.4). Urine concentrations were significantly correlated with values in water but not in lichens. Our findings reveal a complex non-anthropogenic biocontamination with many trace elements in residents of an active volcanic area where thyroid cancer incidence is increased. The possible carcinogenic effect of these chemicals on the thyroid and other tissues cannot be excluded and should be investigated.


Journal of Endocrinological Investigation | 2015

Rare diseases in clinical endocrinology: a taxonomic classification system

Gemma Marcucci; Luisella Cianferotti; Paolo Beck-Peccoz; M. Capezzone; Filomena Cetani; A. Colao; Mv Davi; E.C. degli Uberti; S. Del Prato; Rossella Elisei; Antongiulio Faggiano; Diego Ferone; Carlo Foresta; Laura Fugazzola; Ezio Ghigo; Gilberta Giacchetti; Francesco Giorgino; Andrea Lenzi; Pasqualino Malandrino; Massimo Mannelli; Claudio Marcocci; Laura Masi; Furio Pacini; Giuseppe Opocher; Antonio F. Radicioni; Massimo Tonacchera; Riccardo Vigneri; M. C. Zatelli; M. L. Brandi

PurposeRare endocrine–metabolic diseases (REMD) represent an important area in the field of medicine and pharmacology. The rare diseases of interest to endocrinologists involve all fields of endocrinology, including rare diseases of the pituitary, thyroid and adrenal glands, paraganglia, ovary and testis, disorders of bone and mineral metabolism, energy and lipid metabolism, water metabolism, and syndromes with possible involvement of multiple endocrine glands, and neuroendocrine tumors. Taking advantage of the constitution of a study group on REMD within the Italian Society of Endocrinology, consisting of basic and clinical scientists, a document on the taxonomy of REMD has been produced.Methods and resultsThis document has been designed to include mainly REMD manifesting or persisting into adulthood. The taxonomy of REMD of the adult comprises a total of 166 main disorders, 338 including all variants and subtypes, described into 11 tables.ConclusionsThis report provides a complete taxonomy to classify REMD of the adult. In the future, the creation of registries of rare endocrine diseases to collect data on cohorts of patients and the development of common and standardized diagnostic and therapeutic pathways for each rare endocrine disease is advisable. This will help planning and performing intervention studies in larger groups of patients to prove the efficacy, effectiveness, and safety of a specific treatment.


Frontiers in Endocrinology | 2016

Prognostic Factors for Adrenocortical Carcinoma Outcomes

Claudia Scollo; Marco Russo; Maria Antonietta Trovato; Daniela Sambataro; Dario Giuffrida; Mario Manusia; Giulia Sapuppo; Pasqualino Malandrino; Riccardo Vigneri; Gabriella Pellegriti

Purpose Adrenocortical carcinoma (ACC) is an aggressive tumor characterized by a high recurrence rate and poor response to treatment. This study analyzes a consecutive series of ACC patients to evaluate the prognostic value of various clinical and pathological characteristics. Methods We retrospectively evaluated 32 ACC patients followed at our Medical Center from 1997 to 2015 and evaluated the prognostic value of age at diagnosis, gender, tumor functional status, stage, and type of treatment with respect to overall survival (OS) and disease-free survival (DFS), as determined by Kaplan–Meier curves. Results ACC was associated with hormonal overproduction in 50% of cases, and patients with isolated hyperandrogenism had a better prognosis. Recurrence was observed in 12/26 (46.2%) patients with no evidence of disease after surgery. Tumor size [hazard ratio (HR) 1.32, 95% confidential intervals (CI) 1.12–1.64; p = 0.007], ki-67 (HR 1.06, 95% CI 1.02–1.11; p = 0.009) and advanced stage at diagnosis (III–IV) (HR 6.51, 95% CI 1.65–24.68; p = 0.006) were associated with recurrence in the 26 R0 patients in the univariate analysis. Advanced stage was an independent risk factor for recurrence in the multivariate analysis (HR 8.10, 95% CI 1.55–41.35; p = 0.01). Five-year survival was 40.0%. Positive resection margins (HR 10.61, 95% CI 3.02–38.31; p = < 0.001), ki-67 (HR 1.04, 95% CI 1.01–1.07; p = 0.01) and advanced stage (HR 11.31, 95% CI 1.45–87.76; p = 0.02) were associated with poor survival in all 32 patients, but only positive resection margins were an independent predictor of mortality in the multivariate analysis (HR 6.22, 95% CI 1.44–26.05; p = 0.01). Conclusion ACC has a poor prognosis with a high recurrence rate. Tumor stage at diagnosis and the completeness of surgical excision are the most relevant prognostic factors.


Pediatric Blood & Cancer | 2018

Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors

Marco Russo; Pasqualino Malandrino; Mariacarla Moleti; Francesco Vermiglio; Antonio D'angelo; Giuliana La Rosa; Giulia Sapuppo; Francesca Calaciura; Concetto Regalbuto; Antonino Belfiore; R. Vigneri; Gabriella Pellegriti

To correlate clinical and pathological characteristics at diagnosis with patient long‐term outcomes and to evaluate ongoing risk stratifications in a large series of paediatric differentiated thyroid cancers (DTC).


Frontiers in Endocrinology | 2017

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics

Martina Tavarelli; Pasqualino Malandrino; Paolo Vigneri; Pierina Richiusa; Adele Maniglia; Maria Antonia Violi; Giulia Sapuppo; Veronica Vella; Gabriella Dardanoni; Riccardo Vigneri; Gabriella Pellegriti

Background Anaplastic thyroid cancer (ATC) is a rare but extremely aggressive cancer of the thyroid, contributing up to 30–40% of thyroid cancer-specific mortality. We analyzed ATC characteristics and survival rates in Sicily to evaluate the possible influence of environmental factors. With this aim, data regarding ATC incidences in urban/rural and industrial, iodine-deficient, and volcanic vs control areas were compared in Sicily as well as ATC data from Sicily and USA. Methods Using the Sicilian Register of Thyroid Cancer (SRTC) database incidence, age, gender, tumor size and histotype, extrathyroidal extension, stage, and coexistence with pre-existing differentiated thyroid cancer (DTC) were evaluated in different areas of Sicily and also compared with Surveillance Epidemiology and End Results data in USA. Results Forty-three ATCs were identified in Sicily in the period 2002–2009. In our series only age <70 years at diagnosis (p = 0.01), coexistence with DTC (p = 0.027) and tumor size ≤6 cm (p = 0.012) were significant factors for increased survival at univariate analysis (only age at multivariate analysis). No difference in ATC incidence was found in urban vs rural areas and in iodine-deficient and industrial vs control areas. By contrast, in the volcanic area of Sicily, where DTC incidence is doubled relative to the rest of the island, also ATC incidence was increased. ATC data in Sicily were similar to those reported in the same period in the USA where overall survival rate at 6 and 12 months, however, was smaller. Conclusion The similar ATC data observed in Sicily and USA (having different genetic background and lifestyle) and the increased ATC incidence in the volcanic area of Sicily paralleling the increased incidence of papillary thyroid cancer are compatible with the possibility that casual additional mutations, more frequent in a background of increased cell replication like DCT, are the major causes of ATC rather than genetic background and/or direct environmental influences.


Molecular and Cellular Endocrinology | 2017

Heavy metals in the volcanic environment and thyroid cancer

Riccardo Vigneri; Pasqualino Malandrino; Fiorenza Gianì; Marco Russo; Paolo Vigneri

Collaboration


Dive into the Pasqualino Malandrino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge